Abiopharma

📋 ROY BAYNES (Director) plans to sell 10K shares of TRAVERE THERAPEUTICS, INC. (at $44.22 each, total $431K) Filed: May 01, 2026 | ID: 003899

The Marzetti Company Completes Acquisition of Bachan’s, Inc.

Ready Capital Corporation Announces First Quarter 2026 Results and Webcast Call

Great Elm Capital Corp. (“GECC”) Schedules First Quarter 2026 Earnings Release and Conference Call

Credicorp Ltd.: Credicorp’s Earnings Release and Conference Call 1Q26

Beasley Broadcast Group Announces Settlement of Previously Announced Exchange Offer and Tender Offer

MFS Announces Closed-End Fund Distributions

Farmer Brothers Stockholders Vote to Approve Proposed Acquisition by Royal Cup

Universal Logistics Holdings, Inc. Reports First Quarter 2026 Financial Results; Declares Dividend

Leidos Holdings, Inc. Declares Quarterly Cash Dividend

Madison Square Garden Entertainment Corp. to Host Fiscal 2026 Third Quarter Conference Call

Skycorp Solar Group Limited Announces Acquisition of Remaining 56% Stake in Nanjing Cesun Power Co., Ltd. and $3.0 Million Private Placement

XAI Octagon Floating Rate & Alternative Income Trust Declares its Monthly Common Shares Distribution of $0.225 per Share

Good Times Restaurants to Release Results on May 7, 2026 for the Fiscal 2026 Second Quarter Ended March 31, 2026

XAI Madison Equity Premium Income Fund Declares its Monthly Distribution of $0.060 per Share